Sun Y - Search Results

1

A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer.

Luo Y, Ye Y, Chen Y, Zhang C, Sun Y, Wang C, Ou J. Luo Y, et al. Among authors: sun y. Front Immunol. 2023 Mar 13;14:1140993. doi: 10.3389/fimmu.2023.1140993. eCollection 2023. Front Immunol. 2023. PMID: 36993976 Free PMC article.

2

Prognosis stratification of patients with breast invasive carcinoma based on cysteine metabolism-disulfidptosis affinity.

Zhang Y, Ye Y, Xu A, Luo Y, Sun Y, Zhang W, Ji L. Zhang Y, et al. Among authors: sun y. J Cancer Res Clin Oncol. 2023 Oct;149(13):11979-11994. doi: 10.1007/s00432-023-05028-y. Epub 2023 Jul 8. J Cancer Res Clin Oncol. 2023. PMID: 37422541

3

Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma.

Ye Y, Luo Y, Guo T, Zhang C, Sun Y, Xu A, Ji L, Ou J, Wu SY. Ye Y, et al. Among authors: sun y. Front Endocrinol (Lausanne). 2023 Aug 4;14:1179050. doi: 10.3389/fendo.2023.1179050. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37600707 Free PMC article.

4

Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction.

Sun Y, Yang M, Zhang Q. Sun Y, et al. Ann Transl Med. 2022 Dec;10(24):1379. doi: 10.21037/atm-22-6056. Ann Transl Med. 2022. PMID: 36660642 Free PMC article.

5

Identification and validation of endocrine resistance-related and immune-related long non-coding RNA (lncRNA) signatures for predicting endocrinotherapy response and prognosis in breast cancer.

Yang M, Sun Y, Ji H, Zhang Q. Yang M, et al. Among authors: sun y. Ann Transl Med. 2022 Dec;10(24):1399. doi: 10.21037/atm-22-6158. Ann Transl Med. 2022. PMID: 36660659 Free PMC article.

6

Serum amyloid A 1 induces suppressive neutrophils through the Toll-like receptor 2-mediated signaling pathway to promote progression of breast cancer.

Niu X, Yin L, Yang X, Yang Y, Gu Y, Sun Y, Yang M, Wang Y, Zhang Q, Ji H. Niu X, et al. Among authors: sun y. Cancer Sci. 2022 Apr;113(4):1140-1153. doi: 10.1111/cas.15287. Epub 2022 Feb 13. Cancer Sci. 2022. PMID: 35102665 Free PMC article.

7

Identification and validation of hub genes in CD5-positive diffuse large B-cell lymphoma.

Yang M, Niu X, Yang X, Sun Y, Su W, Zhang J, Wu Q, Wang Y, Zhang Q, Ji H. Yang M, et al. Among authors: sun y. Exp Biol Med (Maywood). 2023 Sep;248(17):1469-1478. doi: 10.1177/15353702231151987. Epub 2023 Feb 27. Exp Biol Med (Maywood). 2023. PMID: 36847415 Free PMC article.

8

Expression of glucose transporter-1 in follicular lymphoma affected tumor-infiltrating immunocytes and was related to progression of disease within 24 months.

Deng Y, Ma J, Zhao S, Yang M, Sun Y, Zhang Q. Deng Y, et al. Among authors: sun y. Transl Oncol. 2023 Feb;28:101614. doi: 10.1016/j.tranon.2022.101614. Epub 2022 Dec 29. Transl Oncol. 2023. PMID: 36584488 Free PMC article.

9

Topoisomerase 3α (TOP3A) Dependent Alternative Lengthening of Telomeres (ALT).

Khandagale P, Sun Y, Saha S, Saha LK, Pommier Y. Khandagale P, et al. Among authors: sun y. bioRxiv [Preprint]. 2024 Nov 18:2024.11.18.624152. doi: 10.1101/2024.11.18.624152. bioRxiv. 2024. PMID: 39803571 Free PMC article. Preprint.

10

Distinctive role of DICER1 mutations in distant metastatic thyroid cancer.

Shi C, Mu Z, Guo W, Zhang X, Sun D, Sun Y, Wang H, Zhang D, Liang J, Lin Y. Shi C, et al. Among authors: sun y. Chin J Cancer Res. 2024 Dec 30;36(6):700-712. doi: 10.21147/j.issn.1000-9604.2024.06.08. Chin J Cancer Res. 2024. PMID: 39802903 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65,477 results

Search Page

Filters